3Daughters
Shelley Amster is a co-founder, advisor, and board member at 3Daughters, focusing on developing innovative healthcare products for women, including a non-hormonal contraceptive IUD. As the founder and principal of ShelleyCO, LLC, Shelley serves as a relationship builder and management integrator for entrepreneurs and executives. Active in various advisory roles, Shelley contributes to organizations such as the Mansfield Bio-Incubator, Nephrogen, and the Advancing Drug Development Forum. Previous experience includes consulting for DxNow, Inc.'s ZyMōt Fertility and business development for Juniper Pharma Services. An advocate for biotechnology and health-related initiatives, Shelley also founded the Annual MassBio CRO CMO Symposium, aimed at enhancing industry practices. Shelley holds a BSMT in Medical Technology from the University of New England and MRHS credentials.
This person is not in any teams
3Daughters
3Daughters is a clinical development company focused on Evolutionary Healthcare for Women. Our first evolution is a frameless, magnetic, nonhormonal intrauterine device (IUD) based on physics and geometry for long-acting contraception. Our unique IUD was designed to improve upon the outdated T-shape frame of current IUDs that causes pain, perforation and expulsion. These problems lead to a ‘fear factor’ for women and practitioners inserting the device. Current IUDs also require dangling strings for retrieval- a nuisance factor for women and their partners. 3Daughters newly designed IUD conforms naturally to a woman’s body and will address the 'fear factor', pain and other problems of current IUDs …with no strings attached! Nearly all women use contraception in their lifetimes, and we plan to make it better.